Terms: = Prostate cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Staging
4 results:
1. Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review.
Laraib U; Sargazi S; Rahdar A; Khatami M; Pandey S
Int J Biol Macromol; 2022 Jan; 195():356-383. PubMed ID: 34920057
[TBL] [Abstract] [Full Text] [Related]
2. muc1 expression in incidental prostate cancer predicts staging and grading on the subsequent radical prostatectomy.
Gunia S; May M; Koch S; Dietel M; Erbersdobler A
Pathol Oncol Res; 2010 Sep; 16(3):371-5. PubMed ID: 19943130
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of muc1 glycoprotein on prostate cancer for selection of targeting molecules.
Burke PA; Gregg JP; Bakhtiar B; Beckett LA; Denardo GL; Albrecht H; De Vere White RW; De Nardo SJ
Int J Oncol; 2006 Jul; 29(1):49-55. PubMed ID: 16773184
[TBL] [Abstract] [Full Text] [Related]
4. Spinal epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach.
Schiff D; O'Neill BP; Suman VJ
Neurology; 1997 Aug; 49(2):452-6. PubMed ID: 9270576
[TBL] [Abstract] [Full Text] [Related]
